EU-IMPLANTABLE_MEDICAL_DEVICES-ART_3_ANX_1

Active Implantable Medical Devices Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Directive 90/385/EEC on Active Implantable Medical Devices, 20 July 1990, amended by Directive 2007/47/EC, 21 September 2007

This list contains hazardous substances for purposes of Directive 90/385/EEC on active implantable medical devices, particularly as regards Article 3 and Annex I (Essential Requirements). This non-exhaustive database is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list). Please note that Regulation (EU) 2017/745 on medical devices has repealed Directive 90/385/EEC and begun to apply from 26 May 2021. Nevertheless, Article 120 of the Regulation provides for a transitional period allowing medical devices, under specified conditions (e.g., placed on the market prior to 26 May 2021), to continue to comply with the Directive. In accordance with the fourth paragraph of Article 120, this period ends 26 May 2025.

RELEVANT LEGISLATION
Last updated 26 April 2024. Database contains 4753 unique substances/entries.
Filter the list

Page 41 of 96
50 Items per Page
Showing 2,001 - 2,050 of 4,753 results.
Substance Name
EC No.
CAS No.
EU CLP (1272/2008)
EU_BA Directive 2000/54/EC
EU REACH: List of SVHC
Creosote oil, acenaphthene fraction; Wash Oil [ complex combination of hydrocarbons produced by the distillation of coal tar and boiling in the range of approximately 240 o C to 280 o C (464°F to 536 °F). Composed primarily of acenaphthene, naphthalene and alkyl naphthalene.]
A complex combination of hydrocarbons produced by the distillation of coal tar and boiling in the range of approximately 240°C to 280°C (464°F to 536°F). Composed primarily of acenaphthene, naphthalene and alkyl naphthalene.
292-605-3
90640-84-9
Carc. 1B
Creosote oil, high-boiling distillate; Wash Oil [The high-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillates, removed. It is crystal free at approximately 5 °C (41°F).]
The high-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillates, removed. It is crystal free at approximately 5°C (41°F).
274-565-9
70321-79-8
Carc. 1B
Creosote oil, low-boiling distillate; Wash Oil [he low-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal, which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillate, removed. It is crystal free at approximately 38 o C (100 oF).]
The low-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal, which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillate, removed. It is crystal free at approximately 38°C (100°F).
274-566-4
70321-80-1
Carc. 1B
crimidine (ISO);2-chloro-6-methylpyrimidin-4- yldimethylamine
208-622-6
535-89-7
Acute Tox. 2
crotonaldehyde; 2-butenal
224-030-0
4170-30-3
Flam. Liq. 2; Muta. 2; Acute Tox. 2; Acute Tox. 3; STOT RE 2; STOT SE 3; Skin Irrit. 2; Eye Dam. 1
crotoxyphos (ISO); 1-phenylethyl 3-(dimethoxyphosphinyloxy) isocrotonate
231-720-5
7700-17-6
Acute Tox. 3
crufomate (ISO); 4-tert-butyl-2-chlorophenyl methyl methylphosphoramidate
206-083-1
299-86-5
Acute Tox. 4
cumene
202-704-5
98-82-8
Flam. Liq. 3; Asp. Tox. 1; STOT SE 3
cyanamide; carbanonitril
206-992-3
420-04-2
Carc. 2; Repr. 2; Acute Tox. 3; STOT RE 2; Skin Corr. 1; Skin Sens. 1; Eye Dam. 1
cyanazine (ISO);2-(4-chloro-6-ethylamino-1,3,5- triazine-2-ylamino)-2-methylpropionitrile
244-544-9
21725-46-2
Acute Tox. 4
cyanofenphos (ISO); O-4-cyanophenyl O-ethyl phenylphosphonothioate
620-377-0
13067-93-1
Acute Tox. 3; STOT SE 1; Acute Tox. 4; Eye Irrit. 2
cyanophos (ISO); O-4-cyanophenyl O,O-dimethyl phosphorothioate
220-130-3
2636-26-2
Acute Tox. 4
cyanthoate (ISO); S-(N-(1-cyano-1-methylethyl)carbamoylmethyl) O,O-diethyl phosphorothioate
223-099-4
3734-95-0
Acute Tox. 2; Acute Tox. 3
cyclanilide (ISO); 1-(2,4-dichloroanilinocarbonyl)cyclopropanecarboxylic acid
CSDCA
419-150-7
113136-77-9
Acute Tox. 4
cyclic 3-(1,2-ethanediylacetale)-estra-5(10),9(11)-diene-3,17-dione
427-230-8
5571-36-8
Repr. 1B; STOT RE 2
cyclohexadeca-1,9-diene
431-730-1
4277-06-9
Skin Irrit. 2; Skin Sens. 1
cyclohexane
203-806-2
110-82-7
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3
cyclohexane-1,2-dicarboxylic anhydride
201-604-9
85-42-7
Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1
yes
cyclohexanol
203-630-6
108-93-0
Acute Tox. 4; STOT SE 3; Skin Irrit. 2
cyclohexanone
203-631-1
108-94-1
Flam. Liq. 3; Acute Tox. 4
cyclohexanone, peroxide [> 91 % solution];cyclohexanone, peroxide [≤ 91 % solution]
235-527-7
12262-58-7
Org. Perox. A; Skin Corr. 1B; Acute Tox. 4
cyclohexanone, peroxide [> 91 % solution];cyclohexanone, peroxide [≤ 91 % solution]
235-527-7
12262-58-7
Org. Perox. C; Acute Tox. 4; Skin Corr. 1B
cycloheximide (ISO);4-{(2R)-2-[(1S,3S,5S)-3,5- dimethyl-2-oxocyclohexyl]-2- hydroxyethyl}piperidine-2,6- dione
200-636-0
66-81-9
Muta. 2; Repr. 1B; Acute Tox. 2
cyclohexyl acrylate
221-319-3
3066-71-5
STOT SE 3; Skin Irrit. 2
cyclohexylamine
203-629-0
108-91-8
Flam. Liq. 3; Repr. 2; Acute Tox. 4; Skin Corr. 1B
cyclohexyldimethoxymethylsilane
CHMMS; CHMS; DYNASYLAN 9407; Z-6187
402-140-1
17865-32-6
Skin Irrit. 2
cyclohexylidene hydroperoxide [> 91 % solution];cyclohexylidene hydroperoxide [≤ 91 % solution]
220-279-4
2699-11-8
Org. Perox. C; Acute Tox. 4; Skin Corr. 1B
cyclohexylidene hydroperoxide [> 91 % solution];cyclohexylidene hydroperoxide [≤ 91 % solution]
220-279-4
2699-11-8
Org. Perox. A; Skin Corr. 1B; Acute Tox. 4
cyclooct-4-en-1-yl methyl carbonate
VIOLIFF
401-620-8
87731-18-8
Skin Sens. 1
cyclopentane
206-016-6
287-92-3
Flam. Liq. 2
cyclopentane-1,2,3,4-tetracarboxylic dianhydride
227-964-7
6053-68-5
Eye Irrit. 2; STOT SE 3
cyclopentanone
204-435-9
120-92-3
Flam. Liq. 3; Eye Irrit. 2; Skin Irrit. 2
cyclopentyl 2-phenylethyl ether
428-340-9
238088-70-5
Skin Irrit. 2
cyclopentyl chloroformate
CHLOROFORMIATE DE CYCLOPENTYLE; CYCLOPENTYLCHLORFORMIAT
411-460-0
50715-28-1
Flam. Liq. 3; Acute Tox. 3; Acute Tox. 4; STOT RE 2; Eye Dam. 1; Skin Sens. 1
cyclopropane
200-847-8
75-19-4
Flam. Gas 1; Press. Gas
cycloxydim (ISO); 2-(N-ethoxybutanimidoyl)-3-hydroxy-5-(tetrahydro-2H-thiopyran-3-yl)cyclohex-2-en-1-one
405-230-9
101205-02-1
Repr. 2
cyflumetofen (ISO); 2-methoxyethyl (RS)-2-(4-tert-butylphenyl)-2-cyano-3-oxo-3-(α,α,α-trifluoro-o-tolyl)propionate
642-974-5
400882-07-7
Carc. 2; Skin Sens. 1A
cyfluthrin (ISO); α-cyano-4-fluoro-3-phenoxybenzyl-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate;α-cyano-4-fluoro-3-phenoxybenzyl-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate; beta-cyfluthrin
269-855-7
68359-37-5
Acute Tox. 2; Acute Tox. 3
cyfluthrin (ISO); α-cyano-4-fluoro-3-phenoxybenzyl-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate;α-cyano-4-fluoro-3-phenoxybenzyl-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate; beta-cyfluthrin
269-855-7
68359-37-5
Acute Tox. 2
cyhexatin (ISO); hydroxytricyclohexylstannane; tri(cyclohexyl)tin hydroxide
236-049-1
13121-70-5
Acute Tox. 4
cymoxanil (ISO); 2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide
261-043-0
57966-95-7
Repr. 2; Acute Tox. 4; STOT RE 2; Skin Sens. 1
cypermethrin cis/trans +/-40/60; (RS)-α-cyano-3-phenoxybenzyl (1RS,3RS;1RS,3SR)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate;cypermethrin cis/trans +/-80/20; (RS)-α-cyano-3-phenoxybenzyl (1RS;3RS; 1RS, 3SR)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate
257-842-9
52315-07-8
Acute Tox. 4; STOT SE 3
cypermethrin cis/trans +/-40/60; (RS)-α-cyano-3-phenoxybenzyl (1RS,3RS;1RS,3SR)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate;cypermethrin cis/trans +/-80/20; (RS)-α-cyano-3-phenoxybenzyl (1RS;3RS; 1RS, 3SR)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate
257-842-9
52315-07-8
Acute Tox. 4; STOT SE 3; Skin Irrit. 2; Skin Sens. 1
cyproconazole (ISO); (2RS,3RS;2RS,3SR)-2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl) butan-2-ol
619-020-1
94361-06-5
Repr. 1B; Acute Tox. 3; STOT RE 2
cyprodinil (ISO); 4-cyclopropyl-6-methyl-N-phenylpyrimidin-2-amine
601-785-8
121552-61-2
Skin Sens. 1
cyprofuram (ISO); N-(3-chlorophenyl)-N-(tetrahydro-2-oxo-3-furyl)cyclopropanecarboxamide
274-050-9
69581-33-5
Acute Tox. 3; Acute Tox. 4
D, L-(N,N-diethyl-2-hydroxy-2-phenylacetamide)
DEM
408-120-9
65197-96-8
Acute Tox. 4; Eye Dam. 1
d-carvone; (5S)-2-methyl-5- (prop-1-en-2-yl)cyclohex-2-en- 1-one
218-827-2
2244-16-8
Skin Sens. 1
D-erythro-hexanoic acid 2,4-dideoxy-3,5-O-(1-methylethylidene)-1,1-dimethylethylester; tert-butyl 2-[(4R, 6S)-6-(hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetate
432-960-5
124655-09-0
Acute Tox. 4
dalapon-sodium; sodium 2,2-dichloropropionate
204-828-5
127-20-8
Skin Irrit. 2; Eye Dam. 1
Page 41 of 96
50 Items per Page
Showing 2,001 - 2,050 of 4,753 results.

Export search results to: